AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14978288 — intervention group
Group type: COMPARATOR
Intervention: Nonaerobic control (nonaerobic control participants in Study 2)
Number of subjects: 0
Study 14978288 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased cardiovascular fitness (both studies)
Number of subjects: 0
Study 11681652 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-soluble sodium pertechnetate
Number of subjects: 2
Study 11681652 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-insoluble tetraphenylarsonium pertechnetate
Number of subjects: 2
Study 11681652 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 2
Study 10653877 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus cisplatin (135 mg/m² and 250 mg/m²)
Number of subjects: 599
Study 10653877 — intervention group
Group type: COMPARATOR
Intervention: Etoposide plus cisplatin (100 mg/m² daily on days 1 to 3, with cisplatin 75 mg/m²)
Number of subjects: 599
Study 10653877 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (all patients)
Number of subjects: 599
Study 10653877 — intervention group
Group type: COMPARATOR
Intervention: Etoposide plus cisplatin (stage IIIB)
Number of subjects: 599
Study 10653877 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (stage IV)
Number of subjects: 599
Study 10653877 — intervention group
Group type: COMPARATOR
Intervention: Etoposide plus cisplatin (stage IV)
Number of subjects: 599
Study 10653877 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life (QOL)
Number of subjects: 599
Study 7716219 — intervention group
Group type: EXPERIMENTAL
Intervention: SPE croissants (1.80 MJ)
Number of subjects: 34
Study 7716219 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat croissants (3.45 MJ)
Number of subjects: 34
Study 7716219 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprivation condition (0.25 h, 2.25 h, 4.75 h)
Number of subjects: 34
Study 2715549 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut allergy (DBPCFC positive)
Number of subjects: 32
Study 2715549 — intervention group
Group type: EXPERIMENTAL
Intervention: Accidental peanut ingestion
Number of subjects: 32
Study 2715549 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of peanut
Number of subjects: 32
Study 2715549 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactions to other legumes and nonlegume nuts
Number of subjects: 32
Study 1085599 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective proximal vagotomy (SPV) without pyloroplasty
Number of subjects: 41
Study 29587582 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront spironolactone 25 mg OD
Number of subjects: 80
Study 29587582 — intervention group
Group type: COMPARATOR
Intervention: Discharge spironolactone 25 mg OD
Number of subjects: 80
Study 28532864 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion palpation tests (Sitting flexion, Standing flexion, Prone knee flexion, Gillet test)
Number of subjects: 50
Study 28532864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain provocation tests (FABER, Posterior shear, Resisted abduction test)
Number of subjects: 50
Study 25697852 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene Expression Profiling (GEP)
Number of subjects: 60
Study 25697852 — intervention group
Group type: COMPARATOR
Intervention: Endomyocardial Biopsy (EMB)
Number of subjects: 60
Study 23791320 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist support splinting and education for 8 weeks
Number of subjects: 54
Study 23791320 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 54
Study 20795383 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunovac vaccine with basic therapy
Number of subjects: 95
Study 20795383 — intervention group
Group type: COMPARATOR
Intervention: Control group with basic therapy only
Number of subjects: 95
Study 20795383 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunovac vaccine
Number of subjects: 95
Study 18421050 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline (alone or in combination)
Number of subjects: 3953
Study 16649880 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong African American Families Program (7-week family skills training program)
Number of subjects: 332
Study 16649880 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 332
Study 12628865 — intervention group
Group type: EXPERIMENTAL
Intervention: Watch PAT100 (WP100) device
Number of subjects: 102
Study 12628865 — intervention group
Group type: COMPARATOR
Intervention: In-laboratory polysomnography
Number of subjects: 102
Study 10823095 — intervention group
Group type: EXPERIMENTAL
Intervention: Amethocaine patch
Number of subjects: 30
Study 10823095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ametop gel
Number of subjects: 30
Study 10823095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10823095 — intervention group
Group type: COMPARATOR
Intervention: Amethocaine patch vs Ametop gel
Number of subjects: 30
Study 2105795 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation group
Number of subjects: 100
Study 2105795 — intervention group
Group type: COMPARATOR
Intervention: Sinus rhythm group
Number of subjects: 100
Study 7001667 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigorous anti-mite measures
Number of subjects: 53
Study 7001667 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anti-mite measures)
Number of subjects: 53
Study 30459073 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (egg white replacement)
Number of subjects: 23
Study 30459073 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary change)
Number of subjects: 23
Study 30459073 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study 28463028 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml 1% lidocaine paracervical block
Number of subjects: 200
Study 28463028 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 µg oral misoprostol
Number of subjects: 200
Study 28463028 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naproxen
Number of subjects: 200
Study 28463028 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 200
Study 27565425 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐Mill therapy (therapy with augmented reality)
Number of subjects: 40
Study 27565425 — intervention group
Group type: COMPARATOR
Intervention: FALLS program (a conventional therapy program)
Number of subjects: 40
Study 24661312 — intervention group
Group type: EXPERIMENTAL
Intervention: iQuit system (tailored printed and SMS text message self-help)
Number of subjects: 602
Study 24661312 — intervention group
Group type: COMPARATOR
Intervention: usual care (control)
Number of subjects: 602
Study 24661312 — intervention group
Group type: EXPERIMENTAL
Intervention: iQuit system
Number of subjects: 602
Study 21798108 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS-MPH
Number of subjects: 156
Study 21798108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 19282706 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (CFNB)
Number of subjects: 50
Study 17990227 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal quinine
Number of subjects: 110
Study 17990227 — intervention group
Group type: COMPARATOR
Intervention: Intravenous quinine
Number of subjects: 110
Study 16255339 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion (5 mEq/kg over 1 hour, followed by 5‐6 mEq/kg daily until recovery or death)
Number of subjects: 53
Study 16255339 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment without high doses of sodium bicarbonate)
Number of subjects: 53
Study 12067873 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl (100 microgram) with hydromorphone (300 microgram)
Number of subjects: 44
Study 12067873 — intervention group
Group type: COMPARATOR
Intervention: Epidural fentanyl (100 microgram) with saline
Number of subjects: 44
Study 12067873 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 9857617 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus infection
Number of subjects: 169
Study 9857617 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed bacterial-viral infections
Number of subjects: 169
Study 9857617 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteropathogenic E. coli (EPEC)
Number of subjects: 169
Study 9857617 — intervention group
Group type: EXPERIMENTAL
Intervention: S. enteritidis
Number of subjects: 169
Study 9857617 — intervention group
Group type: EXPERIMENTAL
Intervention: S. sonnei and E. coli 0127
Number of subjects: 169
Study 7612060 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine bid
Number of subjects: 32
Study 7612060 — intervention group
Group type: COMPARATOR
Intervention: 600 mg ibuprofen racemate tid + placebo
Number of subjects: 32
Study 2503017 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin withdrawal
Number of subjects: 44
Study 2503017 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin reintroduction
Number of subjects: 44
Study 2503017 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin treatment
Number of subjects: 44
Study 2503017 — intervention group
Group type: COMPARATOR
Intervention: No deterioration
Number of subjects: 44
Study 7266950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ritodrine in a 0.1 wt/vol% solution of isotonic saline (N = 12)
Number of subjects: 23
Study 7266950 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ritodrine in isotonic glucose (N = 11)
Number of subjects: 23
Study 31350987 — intervention group
Group type: EXPERIMENTAL
Intervention: NAC + Vitamin A
Number of subjects: 30
Study 31350987 — intervention group
Group type: COMPARATOR
Intervention: NAC
Number of subjects: 30
Study 28292361 — intervention group
Group type: EXPERIMENTAL
Intervention: Per rectal misoprostol (800 µgm)
Number of subjects: 1678
Study 28292361 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular oxytocin (10 units)
Number of subjects: 1678
Study 27187092 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance-based exercise
Number of subjects: 41
Study 27187092 — intervention group
Group type: COMPARATOR
Intervention: Aerobic-based exercise
Number of subjects: 41
Study 27187092 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercise groups
Number of subjects: 41
Study 23249643 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra-intervention group (with additional self-efficacy coaching)
Number of subjects: 227
Study 23249643 — intervention group
Group type: COMPARATOR
Intervention: Standard-intervention group (without additional self-efficacy coaching)
Number of subjects: 227
Study 22743136 — intervention group
Group type: EXPERIMENTAL
Intervention: Light path coupled with tele-assistance service
Number of subjects: 194
Study 22743136 — intervention group
Group type: COMPARATOR
Intervention: Unexposed group (no intervention)
Number of subjects: 194
Study 22743136 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed group (intervention)
Number of subjects: 194
Study 20187995 — intervention group
Group type: EXPERIMENTAL
Intervention: Pear-carrot-sea buckthorn (PCS) shots containing JA inulin (5 g/d)
Number of subjects: 66
Study 20187995 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum-pear-beetroot (PPB) shots containing JA inulin (5 g/d)
Number of subjects: 66
Study 20187995 — intervention group
Group type: EXPERIMENTAL
Intervention: Pear-carrot-sea buckthorn (PCS) shots
Number of subjects: 66
Study 20187995 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum-pear-beetroot (PPB) shots
Number of subjects: 66
Study 20187995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 18550472 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16 detection
Number of subjects: 0
Study 18550472 — intervention group
Group type: COMPARATOR
Intervention: Biopsy diagnoses by clinical center (CC) pathologists
Number of subjects: 0
Study 16555496 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 150mg od
Number of subjects: 1963
Study 16555496 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300mg od
Number of subjects: 1963
Study 12500511 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine 1.5 mg/kg
Number of subjects: 25
Study 12500511 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline 0.075 ml/kg (control)
Number of subjects: 25
Study 10036953 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (LPZ) 30 mg, Clarithromycin (CAM) 400 mg, Metronidazole (MTZ) 500 mg (LCM group)
Number of subjects: 99
Study 10036953 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (RNT) 300 mg, Clarithromycin (CAM) 400 mg, Metronidazole (MTZ) 500 mg (RCM group)
Number of subjects: 99
Study 8775019 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual high‐velocity, low‐amplitude rotatory manipulation
Number of subjects: 60
Study 8775019 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study 2257961 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% butoconazole nitrate cream used for 3 days
Number of subjects: 63
Study 2257961 — intervention group
Group type: COMPARATOR
Intervention: 1% econazole nitrate cream used for 7 days
Number of subjects: 63
Study 7066167 — intervention group
Group type: EXPERIMENTAL
Intervention: Meladinine tablets (Basotherm)
Number of subjects: 8
Study 7066167 — intervention group
Group type: COMPARATOR
Intervention: Oxsoralen capsules (Elder)
Number of subjects: 8
Study 30431298 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy for 3 weeks
Number of subjects: 63
Study 30431298 — intervention group
Group type: COMPARATOR
Intervention: Good sleeping adolescents (control group)
Number of subjects: 63
Study 27854139 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld spectral domain optical coherence tomography (SDOCT) imaging
Number of subjects: 32
Study 27854139 — intervention group
Group type: COMPARATOR
Intervention: Presence of ROP
Number of subjects: 32
Study 26351345 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy with concurrent radiation therapy (RT)
Number of subjects: 303
Study 26351345 — intervention group
Group type: COMPARATOR
Intervention: Preoperative chemotherapy alone (without RT)
Number of subjects: 303
Study 23820228 — intervention group
Group type: EXPERIMENTAL
Intervention: 80-μm flap LASIK
Number of subjects: 36
Study 23820228 — intervention group
Group type: COMPARATOR
Intervention: 120-μm flap LASIK
Number of subjects: 36
Study 21083673 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of esomeprazole twice daily for 12 weeks
Number of subjects: 40
Study 21083673 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 40
Study 19120736 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention via telephone follow-up
Number of subjects: 568
Study 19120736 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention via telephone follow-up with advice
Number of subjects: 568
Study 19120736 — intervention group
Group type: COMPARATOR
Intervention: Control group (no telephone follow-up)
Number of subjects: 568
Study 17210397 — intervention group
Group type: EXPERIMENTAL
Intervention: T3-T4 sympathectomy
Number of subjects: 62
Study 17210397 — intervention group
Group type: COMPARATOR
Intervention: T4 sympathectomy
Number of subjects: 62
Study 15107193 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride 400 mg
Number of subjects: 12
Study 15107193 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisuride 0.2 mg
Number of subjects: 12
Study 15107193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11172176 — intervention group
Group type: EXPERIMENTAL
Intervention: Heptavalent pneumococcal polysaccharide conjugate vaccine
Number of subjects: 1662
Study 11172176 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B vaccine
Number of subjects: 1662
Study 9629950 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram infusion (40 mg/day)
Number of subjects: 60
Study 9629950 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram oral tablets (40 mg/day)
Number of subjects: 60
Study 7827711 — intervention group
Group type: EXPERIMENTAL
Intervention: RC pulse (65% tilt monophasic waveform, 120 mu F capacitor)
Number of subjects: 21
Study 7827711 — intervention group
Group type: EXPERIMENTAL
Intervention: LRC pulse (damped sine wave, 40 mu F capacitor, 37-mH inductor)
Number of subjects: 21
Study 7827711 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both waveforms
Number of subjects: 21
Study 3262318 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 158
Study 3262318 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 158
Study 31608532 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito (2.5 g t.i.d. for 4 weeks)
Number of subjects: 23
Study 31608532 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo for 4 weeks)
Number of subjects: 23
Study 31608532 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito
Number of subjects: 23
Study 30246183 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mm long implants
Number of subjects: 60
Study 30246183 — intervention group
Group type: EXPERIMENTAL
Intervention: 11.5 mm long implants
Number of subjects: 60
Study 30246183 — intervention group
Group type: COMPARATOR
Intervention: Short implants (5 mm)
Number of subjects: 60
Study 30246183 — intervention group
Group type: COMPARATOR
Intervention: Long implants (11.5 mm)
Number of subjects: 60
Study 28860264 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servo ventilation
Number of subjects: 0
Study 28860264 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 26588217 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted thoracic paravertebral block with propofol general anesthesia (PPA group)
Number of subjects: 247
Study 26588217 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl with sevoflurane general anesthesia (GA group)
Number of subjects: 247
Study 24349149 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote SDV
Number of subjects: 32
Study 24349149 — intervention group
Group type: COMPARATOR
Intervention: Traditional on-site SDV
Number of subjects: 32
Study 24349149 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote SDV (Adult)
Number of subjects: 32
Study 24349149 — intervention group
Group type: COMPARATOR
Intervention: Traditional on-site SDV (Adult)
Number of subjects: 32
Study 24349149 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote SDV (Pediatric)
Number of subjects: 32
Study 24349149 — intervention group
Group type: COMPARATOR
Intervention: Traditional on-site SDV (Pediatric)
Number of subjects: 32
Study 21147907 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day zinc treatment
Number of subjects: 1622
Study 21147907 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day zinc treatment
Number of subjects: 1622
Study 18418313 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodinated contrast media (various types including high osmolal, low osmolal, and iso-osmolal)
Number of subjects: 0
Study 15838437 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoscreening
Number of subjects: 605
Study 15838437 — intervention group
Group type: COMPARATOR
Intervention: Traditional screening
Number of subjects: 605
Study 12718838 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined DTPw‐HBV/Hib vaccine
Number of subjects: 0
Study 12718838 — intervention group
Group type: COMPARATOR
Intervention: Separate DTPw‐HBV and Hib vaccines
Number of subjects: 0
Study 10484257 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse case management
Number of subjects: 427
Study 10484257 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 427
Study 8966350 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Burst Stimulus (DBS)
Number of subjects: 57
Study 8966350 — intervention group
Group type: COMPARATOR
Intervention: Train-of-Four (TOF)
Number of subjects: 57
Study 8966350 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 57
Study 1864478 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 64
Study 1864478 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 64
Study 1864478 — intervention group
Group type: COMPARATOR
Intervention: Sodium Valproate
Number of subjects: 64
Study 6628794 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide
Number of subjects: 24
Study 6628794 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone
Number of subjects: 24
Study 31542145 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine education (n=263)
Number of subjects: 521
Study 31542145 — intervention group
Group type: COMPARATOR
Intervention: Sun safety education (attention control, n=128)
Number of subjects: 521
Study 31542145 — intervention group
Group type: COMPARATOR
Intervention: No message control (n=130)
Number of subjects: 521
Study 29408967 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CPVB+SGB (5mL and 3mL of levobupivacaine 0.5%)
Number of subjects: 28
Study 29408967 — intervention group
Group type: COMPARATOR
Intervention: Single CPVB (5mL of levobupivacaine 0.5%)
Number of subjects: 28
Study 27130714 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli sprouts (BS) 100 g daily for 3 days
Number of subjects: 40
Study 27130714 — intervention group
Group type: COMPARATOR
Intervention: Alfalfa sprouts (AS) 100 g daily for 3 days (Control)
Number of subjects: 40
Study 24587320 — intervention group
Group type: EXPERIMENTAL
Intervention: Active smoking of one cigarette
Number of subjects: 12
Study 24587320 — intervention group
Group type: COMPARATOR
Intervention: Control (not smoking)
Number of subjects: 12
Study 22712582 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraprostatic injection of 200 U OnabotulinumtoxinA (BTX-A)
Number of subjects: 64
Study 21130386 — intervention group
Group type: EXPERIMENTAL
Intervention: CIC‐HFA 80 μg
Number of subjects: 707
Study 21130386 — intervention group
Group type: EXPERIMENTAL
Intervention: CIC‐HFA 160 μg
Number of subjects: 707
Study 21130386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 707
Study 17034536 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical methyl aminolaevulinate (MAL)-photodynamic therapy (PDT)
Number of subjects: 119